Medical Statistics in Drug Development and Regulatory Approval

Author:

Yingngam Bancha1ORCID

Affiliation:

1. Ubon Ratchathani University, Thailand

Abstract

In the rapidly evolving field of pharmaceuticals, the application of medical statistics has become increasingly important. This chapter provides an insightful overview of the integral role that statistical analysis plays in the journey of drug development, highlighting its impact from preclinical trials to phase III studies as well as its significance in regulatory decision-making. This chapter begins by establishing the foundational principles of statistical methods in clinical research. Specific statistical models and techniques used to ensure the safety and efficacy of new drugs have been explored. Key topics include experimental design, hypothesis testing, data interpretation, and the management of potential biases. This chapter highlights the indispensability of robust statistical practices for achieving reliable and scientifically sound results, which are critical for gaining regulatory approval. In the future, this chapter discusses emerging trends in biostatistics and their potential impact on future drug development and approval processes.

Publisher

IGI Global

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3